Physician profile
Arun Kanmanthareddy
NPI 1013143122
$41,138.70
in general payments reported to CMS, 2019-2025
26 companies · $26K in 2025
The $26K reported for 2025 was more than what 94% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,451 · 2020: $1,381 · 2021: $1,511 · 2022: $2,262 · 2023: $3,353 · 2024: $1,964 · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26K · Food and Beverage: $3,704 · Travel and Lodging: $1,910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25,920.00 |
| Food and Beverage | $3,704.17 |
| Travel and Lodging | $1,909.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $26,895.19 | 2021-2025 | Corevalve Evolut R, Telescope, Onyx Frontier |
| Boston Scientific Corporation | $3,637.06 | 2019-2025 | Watchman Access System, Watchman Flx, Avvigo Guidance System |
| Edwards Lifesciences Corporation | $3,464.06 | 2019-2024 | Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $2,572.16 | 2019-2025 | Amplatzer Amulet, Navitor, Mitraclip |
| Medtronic Vascular, INC. | $1,706.26 | 2019-2020 | |
| Philips North America LLC | $723.20 | 2024 | (9525) Intracardiac Und |
| Shockwave Medical, INC | $658.40 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $227.73 | 2019-2023 | Diamondback Coronary |
| Biotronik INC. | $189.77 | 2022-2025 | Orsiro Mission |
| Amgen INC. | $170.91 | 2021-2024 | Repatha |
| Abiomed | $146.13 | 2022 | |
| Teleflex LLC | $138.75 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $123.44 | 2019-2022 | |
| Pfizer INC. | $84.77 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $67.68 | 2019-2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $61.47 | 2024 | |
| Janssen Pharmaceuticals, INC | $54.53 | 2019-2021 | |
| Terumo Medical Corporation | $35.76 | 2020-2022 | |
| Baylis Medical Company INC | $31.45 | 2021 | |
| Impulse Dynamics (USA) INC. | $28.62 | 2023 | Optimizer |
| Actelion Pharmaceuticals US, INC. | $27.13 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $26.90 | 2021 | |
| Livanova USA, INC. | $23.50 | 2023 | Protekduo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.69 | 2023 | Jardiance |
| Penumbra, INC. | $14.14 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Kanmanthareddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.